BMO Capital lowered the firm’s price target on Corpay (CPAY) to $440 from $450 but keeps an Outperform rating on the shares after its Q4 results. The company’s underlying trends are encouraging, though macro headwinds weighed on its 2025 guidance, the analyst tells investors in a research note. A more modest macro headwind was anticipated, and BMO expects Corpay shares to give back some year-to-date appreciation, the firm added.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPAY:
- Corpay price target lowered at Raymond James, says buy shares on weakness
- Corpay price target raised to $445 from $415 at Keefe Bruyette
- Corpay price target raised to $440 from $408 at Baird
- Corpay price target raised to $380 from $350 at Morgan Stanley
- Corpay Reports Record 2024 Financial Performance